Bill is founder and owner of BiStro Biotech Consulting LLC. Prior to retiring from Johnson & Johnson in 2016, Dr. Strohl was VP and Head, Janssen BioTherapeutics, Janssen R&D, J&J, where he headed up biologics discovery and early development. Before that, Bill was head of Biologics Research, the discovery arm of Janssen BioTherapeutics. Before joining J&J, he was at Merck and Co, leading the Biologics discovery efforts, where he was involved in two biotechnology company acquisitions.
This person is not in the org chart
This person is not in any offices